Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05216991 · ClinicalTrials.gov registry record
Sugammadex and Quantitative Monitoring in "Fast-Track Anesthesia" During Liver Transplantation
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 97
- Enrollment target
NCT05216991: Completed study, sponsored by Mayo Clinic.
NCT05216991 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 97 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05216991 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
Study Summary
The purpose of this research is to estimate the frequency of postoperative lasting muscle weakness in patients receiving Sugammadex after undergoing liver transplant surgery by using electromyographic device (EMG), such as TetraGraph.
Primary Outcome
Number of patients to experience postoperative residual weakness after receiving Sugammadex as standard of care for liver transplant surgery. Postoperative residual weakness is defined as train-of-four ratio (TOF) \<0.9. Train-of-four is a test used to measure the level of neuromuscular blockage through delivery of four consecutive stimuli to a nerve. Measurement of the muscle's response (number of twitches 1-4) to the stimuli indicates the degree of paralysis. This is measured by an EMG device
Interventions
- OTHER TetraGraph on dominant hand
- OTHER TetraGraph on non-dominant hand
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2022-10-20 |
| Est. Completion | 2025-01-21 |
What the finished NCT05216991 record still lists
NCT05216991 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 97 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which TetraGraph on dominant hand is the first listed.
NCT05216991 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05216991 about?
NCT05216991 is a clinical study titled "Sugammadex and Quantitative Monitoring in "Fast-Track Anesthesia" During Liver Transplantation". The purpose of this research is to estimate the frequency of postoperative lasting muscle weakness in patients receiving Sugammadex after undergoing liver transplant surgery by using electromyographic device (EMG), such as TetraGraph.
What is the current status of trial NCT05216991?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2022-10-20. Estimated completion is 2025-01-21.
What interventions are being tested in trial NCT05216991?
The interventions under investigation include: TetraGraph on dominant hand (OTHER), TetraGraph on non-dominant hand (OTHER).
Who is sponsoring clinical trial NCT05216991?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03948490 · 97 participants · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
- NCT04140487 · 97 participants · Phase 1
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- NCT04196413 · 97 participants · Phase 1
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
- NCT05223816 · 97 participants · Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI